| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 27, 2007
Accepted on August 13, 2007
Pediatric Endocrinology Division and Department of Neonatology, Children's Hospital, University of Bonn, Germany
* To whom correspondence should be addressed. E-mail: joachim.woelfle{at}ukb.uni-bonn.de.
Background: Preterm infants with very low birth weight frequently exhibit impaired longitudinal growth during the first years of life. Recently, the d3-isoform (genomic deletion of exon 3) of the growth hormone receptor (GHR) has been linked to an increased responsiveness to growth hormone (GH).
Objective: To test whether the GHRd3 isoform is associated with postnatal catch-up growth in very low birth weight preterm infants.
Design and Patients: We compared the postnatal growth pattern of 77 otherwise healthy preterm infants (mean gestational age 28.5 weeks, range 23–35 weeks) with a birth weight below 1500 g (mean birth weight 941 g) to their GHR exon 3 genotype, which was analyzed by multiplex PCR. On examination, mean age of the children was 6.0 years (range 4.2–8.0 years).
Results: Children homozygous or heterozygous for the GHRd3-allele showed a significant higher rate of postnatal catch-up, compared to those homozygous for the full-length allele.
Conclusions: Our results define the GHR exon 3 genotype as a predictor for the postnatal growth pattern of very low birth weight preterm infants. Those who carry at least one GHRd3 allele are more likely to catch-up.
This article has been cited by other articles:
![]() |
L. Audi, A. Carrascosa, C. Esteban, M. Fernandez-Cancio, P. Andaluz, D. Yeste, R. Espadero, M. L. Granada, H. Wollmann, L. Fryklund, et al. The exon 3-deleted/full-length Growth Hormone Receptor Polymorphism Does Not Influence the Effect of Puberty or Growth Hormone Therapy on Glucose Homeostasis in Short Non-Growth Hormone-Deficient Small-for-Gestational-Age Children: Results from a Two-Year Controlled Prospective Study J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2709 - 2715. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |